Skip to main content
. 2021 Nov 22;13(22):5863. doi: 10.3390/cancers13225863

Table 1.

BRAF, PTEN, and CDKN2A status in A375, WM983B, and WM115 BRAF-mutant melanoma cell lines [33].

Cell Line BRAF Status PTEN Status CDKN2A Status
A375 V600E WT p.E10, p.E18
WM983B V600E WT p.P63L
WM115 V600D Loss of heterozygosity [34] Homozygous Deletion [35]